phenylbutazone has been researched along with Chronic Kidney Failure in 7 studies
Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two patients had phenylbutazone-induced systemic vasculitis syndrome." | 7.67 | Phenylbutazone-induced systemic vasculitis with crescentic glomerulonephritis. ( Dobbie, JW; Jones, JM; Leung, AC; McLay, A, 1985) |
| "Two patients had phenylbutazone-induced systemic vasculitis syndrome." | 3.67 | Phenylbutazone-induced systemic vasculitis with crescentic glomerulonephritis. ( Dobbie, JW; Jones, JM; Leung, AC; McLay, A, 1985) |
| " Due to many different pharmacokinetic properties, no perfect rules for dosage in acute or chronic hemodialysis exist." | 1.27 | Tranquilizers, analgetics and antidepressants in patients treated with hemodialysis. ( Forycki, Z; Ibe, K; Martens, F; Thalhofer, S, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heidelmann, G | 1 |
| Burck, G | 1 |
| Dauterstedt, W | 1 |
| Heinrich, JJ | 1 |
| Ohlmer, R | 1 |
| Held, H | 1 |
| Enderle, C | 1 |
| Kshirsagar, NA | 1 |
| Pahujani, SM | 1 |
| Paul, T | 1 |
| Sheth, UK | 1 |
| van Peer, AP | 1 |
| Belpaire, FM | 1 |
| Bogaert, MG | 1 |
| Forycki, Z | 1 |
| Martens, F | 1 |
| Thalhofer, S | 1 |
| Ibe, K | 1 |
| Leung, AC | 1 |
| McLay, A | 1 |
| Dobbie, JW | 1 |
| Jones, JM | 1 |
| Serre, H | 1 |
| Simon, L | 1 |
| Claustre, J | 1 |
7 other studies available for phenylbutazone and Chronic Kidney Failure
| Article | Year |
|---|---|
[Indications for and methods of allopurinol-benzbromarone combination therapy in the treatment of hyperuricemic metabolic disorders].
Topics: Adult; Aged; Allopurinol; Benzbromarone; Benzofurans; Drug Interactions; Drug Therapy, Combination; | 1982 |
Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency.
Topics: Adult; Blood Urea Nitrogen; Creatinine; Female; Half-Life; Humans; Kidney Failure, Chronic; Male; Me | 1976 |
Phenylbutazone protein binding in normal subjects and hypoproteinemic patients.
Topics: Adult; Female; Humans; Hypoproteinemia; Kidney Failure, Chronic; Liver Cirrhosis; Male; Middle Aged; | 1979 |
In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in rabbits with experimental renal failure.
Topics: Animals; Antipyrine; In Vitro Techniques; Kidney Failure, Chronic; Kinetics; Liver; Oxidation-Reduct | 1978 |
Tranquilizers, analgetics and antidepressants in patients treated with hemodialysis.
Topics: Acetaminophen; Acute Kidney Injury; Analgesics; Anti-Anxiety Agents; Antidepressive Agents; Benzodia | 1985 |
Phenylbutazone-induced systemic vasculitis with crescentic glomerulonephritis.
Topics: Acute Kidney Injury; Aged; Drug Eruptions; Drug Hypersensitivity; Eosinophilia; Female; Glomerulonep | 1985 |
[Uric acid inhibitors in the treatment of gout. Apropos of 126 cases].
Topics: Adult; Aged; Allopurinol; Colchicine; Drug Synergism; Female; Gout; Humans; Kidney Calculi; Kidney F | 1970 |